Overview of Clinical Outcome and Therapeutic Effectiveness of Favipiravir in Patients with COVID-19 Admitted to Intensive Care Unit, Riyadh, Saudi Arabia

{ 'indexed': {'date-parts': [[2022, 2, 15]], 'date-time': '2022-02-15T18:43:50Z', 'timestamp': 1644950630853}, 'reference-count': 60, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2022, 2, 1]], 'date-time': '2022-02-01T00:00:00Z', 'timestamp': 1643673600000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2022, 1, 25]], 'date-time': '2022-01-25T00:00:00Z', 'timestamp': 1643068800000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by-nc-nd/4.0/'}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'short-container-title': ['Journal of Infection and Public Health'], 'published-print': {'date-parts': [[2022, 2]]}, 'DOI': '10.1016/j.jiph.2022.01.013', 'type': 'journal-article', 'created': {'date-parts': [[2022, 2, 15]], 'date-time': '2022-02-15T18:28:22Z', 'timestamp': 1644949702000}, 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': [ 'Overview of Clinical Outcome and Therapeutic Effectiveness of Favipiravir in Patients with ' 'COVID-19 Admitted to Intensive Care Unit, Riyadh, Saudi Arabia'], 'prefix': '10.1016', 'author': [ {'given': 'Abbas Al', 'family': 'Mutair', 'sequence': 'first', 'affiliation': []}, {'given': 'Jinan', 'family': 'Shamou', 'sequence': 'additional', 'affiliation': []}, {'given': 'Saad', 'family': 'Alhumaid', 'sequence': 'additional', 'affiliation': []}, {'given': 'Laila', 'family': 'Layqah', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gasmelseed Y.', 'family': 'Ahmad', 'sequence': 'additional', 'affiliation': []}, {'given': 'Koritala', 'family': 'Thoyaja', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mohammed Al', 'family': 'Mohaini', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sana', 'family': 'Almahmoud', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mazin', 'family': 'Barry', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amjad', 'family': 'Khan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kuldeep', 'family': 'Dhama', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lamiaa Hamad', 'family': 'Al-Jamea', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alxeander', 'family': 'Woodman', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ali A.', 'family': 'Rabaan', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'issue': '2', 'key': '10.1016/j.jiph.2022.01.013_bib1', 'doi-asserted-by': 'crossref', 'first-page': '167', 'DOI': '10.1007/s10238-020-00671-y', 'article-title': '"Emerging treatment strategies for COVID-19 infection,"', 'volume': 'vol. 21', 'author': 'Gavriatopoulou', 'year': '2021', 'journal-title': '(in eng), Clinical and experimental medicine'}, { 'key': '10.1016/j.jiph.2022.01.013_bib2', 'unstructured': 'T. Koritala et al., "A narrative review of emergency use authorization ' 'versus full FDA approval and its effect on COVID-19 vaccination ' 'hesitancy."'}, { 'issue': '4', 'key': '10.1016/j.jiph.2022.01.013_bib3', 'article-title': '"Arguments in favour of remdesivir for treating SARS-CoV-2 infections,"', 'volume': 'vol. 55', 'author': 'Ko', 'year': '2020', 'journal-title': '(in eng), Int J Antimicrob Agents'}, { 'key': '10.1016/j.jiph.2022.01.013_bib4', 'unstructured': '"World Health Organization Coronavirus disease (COVID-19) weekly ' 'epidemiological update and weekly operational update." ' 'https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports ' '(accessed.'}, { 'issue': '1', 'key': '10.1016/j.jiph.2022.01.013_bib5', 'first-page': '1', 'article-title': '"Immune responses in COVID-19 and potential vaccines: Lessons learned ' 'from SARS and MERS epidemic,"', 'volume': 'vol. 38', 'author': 'Prompetchara', 'year': '2020', 'journal-title': '(in eng), Asian Pac J Allergy Immunol'}, { 'issue': '7', 'key': '10.1016/j.jiph.2022.01.013_bib6', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.jiph.2020.05.026', 'article-title': '"Clinical characteristics of COVID-19 in Saudi Arabia: A national ' 'retrospective study," (in eng)', 'volume': 'vol. 13', 'author': 'Alsofayan', 'year': '2020', 'journal-title': 'Journal of infection and public health'}, { 'issue': '13', 'key': '10.1016/j.jiph.2022.01.013_bib7', 'doi-asserted-by': 'crossref', 'first-page': '1239', 'DOI': '10.1001/jama.2020.2648', 'article-title': '"Characteristics of and Important Lessons From the Coronavirus Disease ' '2019 (COVID-19) Outbreak in China: Summary of a Report of 72\u202f314 ' 'Cases From the Chinese Center for Disease Control and Prevention," (in ' 'eng)', 'volume': 'vol. 323', 'author': 'Wu', 'year': '2020', 'journal-title': 'Jama'}, { 'issue': '18', 'key': '10.1016/j.jiph.2022.01.013_bib8', 'doi-asserted-by': 'crossref', 'first-page': '1708', 'DOI': '10.1056/NEJMoa2002032', 'article-title': 'Clinical Characteristics of Coronavirus Disease 2019 in China," (in ' 'eng)', 'volume': 'vol. 382', 'author': 'Guan', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'issue': '11', 'key': '10.1016/j.jiph.2022.01.013_bib9', 'doi-asserted-by': 'crossref', 'first-page': '1061', 'DOI': '10.1001/jama.2020.1585', 'article-title': '"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel ' 'Coronavirus-Infected Pneumonia in Wuhan, China," (in eng)', 'volume': 'vol. 323', 'author': 'Wang', 'year': '2020', 'journal-title': 'Jama'}, { 'issue': '24', 'key': '10.1016/j.jiph.2022.01.013_bib10', 'doi-asserted-by': 'crossref', 'first-page': '2372', 'DOI': '10.1056/NEJMc2010419', 'article-title': '"Clinical Characteristics of Covid-19 in New York City," in', 'volume': 'vol. 382', 'author': 'Goyal', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'issue': '19', 'key': '10.1016/j.jiph.2022.01.013_bib11', 'doi-asserted-by': 'crossref', 'first-page': '1787', 'DOI': '10.1056/NEJMoa2001282', 'article-title': '"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe ' 'Covid-19," (in eng)', 'volume': 'vol. 382', 'author': 'Cao', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'issue': '1', 'key': '10.1016/j.jiph.2022.01.013_bib12', 'doi-asserted-by': 'crossref', 'first-page': '105', 'DOI': '10.1016/j.cmi.2020.09.014', 'article-title': 'Efficacy of corticosteroid treatment for hospitalized patients with ' 'severe COVID-19: a multicentre study," (in eng)', 'volume': 'vol. 27', 'author': 'Bartoletti', 'year': '2021', 'journal-title': 'Clinical microbiology and infection: the official publication of the ' 'European Society of Clinical Microbiology and Infectious Diseases'}, { 'issue': '8', 'key': '10.1016/j.jiph.2022.01.013_bib13', 'doi-asserted-by': 'crossref', 'first-page': '693', 'DOI': '10.1056/NEJMoa2021436', 'article-title': 'Dexamethasone in Hospitalized Patients with Covid-19," (in eng)', 'volume': 'vol. 384', 'author': 'Horby', 'year': '2021', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.jiph.2022.01.013_bib14', 'article-title': '"Clinical efficacy of hydroxychloroquine in patients with covid-19 ' 'pneumonia who require oxygen: observational comparative study using ' 'routine care data,"', 'volume': 'vol. 369', 'author': 'Mahévas', 'year': '2020', 'journal-title': 'Bmj'}, { 'issue': '1139', 'key': '10.1016/j.jiph.2022.01.013_bib15', 'doi-asserted-by': 'crossref', 'first-page': '550', 'DOI': '10.1136/postgradmedj-2020-137785', 'article-title': '"Hydroxychloroquine and COVID-19,"', 'volume': 'vol. 96', 'author': 'Sinha', 'year': '2020', 'journal-title': 'Postgraduate Medical Journal'}, { 'issue': '1', 'key': '10.1016/j.jiph.2022.01.013_bib16', 'doi-asserted-by': 'crossref', 'first-page': '19', 'DOI': '10.1016/j.cmi.2020.08.022', 'article-title': '"Effect of hydroxychloroquine with or without azithromycin on the ' 'mortality of coronavirus disease 2019 (COVID-19) patients: a systematic ' 'review and meta-analysis," (in eng)', 'volume': 'vol. 27', 'author': 'Fiolet', 'year': '2021', 'journal-title': 'Clinical microbiology and infection: the official publication of the ' 'European Society of Clinical Microbiology and Infectious Diseases'}, { 'issue': '16', 'key': '10.1016/j.jiph.2022.01.013_bib17', 'article-title': 'Hydroxychloroquine, a less toxic derivative of chloroquine, is ' 'effective in inhibiting SARS-CoV-2 infection in vitro," (in eng)', 'volume': 'vol. 6', 'author': 'Liu', 'year': '2020', 'journal-title': 'Cell Discov'}, { 'issue': '19', 'key': '10.1016/j.jiph.2022.01.013_bib18', 'doi-asserted-by': 'crossref', 'first-page': '1813', 'DOI': '10.1056/NEJMoa2007764', 'article-title': '"Remdesivir for the Treatment of Covid-19 - Final Report," (in eng)', 'volume': 'vol. 383', 'author': 'Beigel', 'year': '2020', 'journal-title': 'The New England journal of medicine'}, { 'key': '10.1016/j.jiph.2022.01.013_bib19', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ejmech.2020.112527', 'article-title': '"A promising antiviral candidate drug for the COVID-19 pandemic: A ' 'mini-review of remdesivir," (in eng)', 'volume': 'vol. 201', 'author': 'Liang', 'year': '2020', 'journal-title': 'European journal of medicinal chemistry'}, { 'issue': '4', 'key': '10.1016/j.jiph.2022.01.013_bib20', 'doi-asserted-by': 'crossref', 'first-page': '397', 'DOI': '10.1080/17460441.2019.1581171', 'article-title': '"Broad-spectrum coronavirus antiviral drug discovery," (in eng)', 'volume': 'vol. 14', 'author': 'Totura', 'year': '2019', 'journal-title': 'Expert opinion on drug discovery'}, { 'issue': '3', 'key': '10.1016/j.jiph.2022.01.013_bib21', 'doi-asserted-by': 'crossref', 'first-page': '1002', 'DOI': '10.1016/j.xphs.2020.11.019', 'article-title': '"Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: ' 'A Clinical and Translational Medicine Perspective," (in eng)', 'volume': 'vol. 110', 'author': 'Perazzolo', 'year': '2021', 'journal-title': 'J Pharm Sci'}, { 'issue': '3', 'key': '10.1016/j.jiph.2022.01.013_bib22', 'doi-asserted-by': 'crossref', 'first-page': '252', 'DOI': '10.1136/thorax.2003.012658', 'article-title': '"Role of lopinavir/ritonavir in the treatment of SARS: initial ' 'virological and clinical findings," (in eng)', 'volume': 'vol. 59', 'author': 'Chu', 'year': '2004', 'journal-title': 'Thorax'}, { 'key': '10.1016/j.jiph.2022.01.013_bib23', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.antiviral.2020.104786', 'article-title': 'Remdesivir, lopinavir, emetine, and homoharringtonine inhibit ' 'SARS-CoV-2 replication in vitro," (in eng)', 'volume': 'vol. 178', 'author': 'Choy', 'year': '2020', 'journal-title': 'Antiviral Res'}, { 'key': '10.1016/j.jiph.2022.01.013_bib24', 'doi-asserted-by': 'crossref', 'first-page': '17', 'DOI': '10.1016/j.antiviral.2014.02.014', 'article-title': '"Successful treatment of advanced Ebola virus infection with T-705 ' '(favipiravir) in a small animal model," (in eng)', 'volume': 'vol. 105', 'author': 'Oestereich', 'year': '2014', 'journal-title': 'Antiviral Res'}, { 'issue': '10', 'key': '10.1016/j.jiph.2022.01.013_bib25', 'doi-asserted-by': 'crossref', 'first-page': '1288', 'DOI': '10.1093/cid/ciw571', 'article-title': '"Clinical and Virological Characteristics of Ebola Virus Disease ' 'Patients Treated With Favipiravir (T-705)-Sierra Leone, 2014," (in eng)', 'volume': 'vol. 63', 'author': 'Bai', 'year': '2016', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/j.jiph.2022.01.013_bib26', 'doi-asserted-by': 'crossref', 'first-page': '85', 'DOI': '10.1016/j.antiviral.2018.03.003', 'article-title': '"Favipiravir as a potential countermeasure against neglected and ' 'emerging RNA viruses," (in eng)', 'volume': 'vol. 153', 'author': 'Delang', 'year': '2018', 'journal-title': 'Antiviral Res'}, { 'issue': '4', 'key': '10.1016/j.jiph.2022.01.013_bib27', 'doi-asserted-by': 'crossref', 'DOI': '10.1136/bmjopen-2020-047495', 'article-title': 'Multicentre randomised double-blinded placebo-controlled trial of ' 'favipiravir in adults with mild COVID-19," (in eng)', 'volume': 'vol. 11', 'author': 'Bosaeed', 'year': '2021', 'journal-title': 'BMJ Open'}, { 'issue': '7', 'key': '10.1016/j.jiph.2022.01.013_bib28', 'doi-asserted-by': 'crossref', 'first-page': '449', 'DOI': '10.2183/pjab.93.027', 'article-title': '"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA ' 'polymerase," (in eng)', 'volume': 'vol. 93', 'author': 'Furuta', 'year': '2017', 'journal-title': 'Proceedings of the Japan Academy. Series B, Physical and biological ' 'sciences'}, { 'issue': '9', 'key': '10.1016/j.jiph.2022.01.013_bib29', 'doi-asserted-by': 'crossref', 'first-page': '1247', 'DOI': '10.1016/j.jiph.2021.08.022', 'article-title': 'Favipiravir versus standard of care in patients with severe COVID-19 ' 'infections: A retrospective comparative study," (in eng)', 'volume': 'vol. 14', 'author': 'Almoosa', 'year': '2021', 'journal-title': 'J Infect Public Health'}, { 'issue': '10', 'key': '10.1016/j.jiph.2022.01.013_bib30', 'doi-asserted-by': 'crossref', 'first-page': '1192', 'DOI': '10.1016/j.eng.2020.03.007', 'article-title': 'Experimental Treatment with Favipiravir for COVID-19: An Open-Label ' 'Control Study', 'volume': 'vol. 6', 'author': 'Cai', 'year': '2020', 'journal-title': 'Engineering'}, { 'key': '10.1016/j.jiph.2022.01.013_bib31', 'unstructured': '"The Kingdom of Saudi Arabia\'s experience in health preparedness and ' 'response to COVID-19 pandemic." Riyadh: Government of Saudi Arabia; ' '2020. ' 'https://www.moh.gov.sa/en/Ministry/MediaCenter/Publications/Documents/COVID-19-NATIONAL.pdf ' '(accessed accessed 6 December 2020).).'}, { 'key': '10.1016/j.jiph.2022.01.013_bib32', 'unstructured': '"Saudi Arabia physicians total number 2010–2019 [Internet]." Hamburg: ' 'Statista; 2021. ' 'https://www.statista.com/statistics/608539/total-number-of-physicians-in-saudi-arabia ' '(accessed accessed 1 March 2021)).'}, { 'key': '10.1016/j.jiph.2022.01.013_bib33', 'unstructured': '"Coronavirus disease 19 guidelines. Riyadh: Ministry of Health, Saudi ' 'Arabia; 2020." Ministry of Health, Saudi Arabia; 2020. ' 'https://www.moh.gov.sa/en/Ministry/MediaCenter/Publications/Pages/covid19.aspx ' '(accessed 31 December 2020).'}, { 'key': '10.1016/j.jiph.2022.01.013_bib34', 'unstructured': 'A. Khorram-Manesh, K. Goniewicz, A. Hertelendy, and M. Dulebenets, ' 'Handbook of Disaster and Emergency Management (2nd Edition, 2021). ' '2021.'}, { 'issue': '1', 'key': '10.1016/j.jiph.2022.01.013_bib35', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/healthcare9010014', 'article-title': 'Increased Emergency Calls during the COVID-19 Pandemic in Saudi Arabia: ' 'A National Retrospective Study', 'volume': 'vol. 9', 'author': 'Al-Wathinani', 'year': '2021', 'journal-title': 'Healthcare'}, { 'issue': '1', 'key': '10.1016/j.jiph.2022.01.013_bib36', 'doi-asserted-by': 'crossref', 'first-page': '98', 'DOI': '10.2991/jegh.k.200928.001', 'article-title': '"Clinical Characteristics and Predictors of 28-Day Mortality in 352 ' 'Critically Ill Patients with COVID-19: A Retrospective Study," (in eng)', 'volume': 'vol. 11', 'author': 'Alharthy', 'year': '2021', 'journal-title': 'Journal of epidemiology and global health'}, { 'issue': '10239', 'key': '10.1016/j.jiph.2022.01.013_bib37', 'doi-asserted-by': 'crossref', 'first-page': '1763', 'DOI': '10.1016/S0140-6736(20)31189-2', 'article-title': 'Epidemiology, clinical course, and outcomes of critically ill adults ' 'with COVID-19 in New York City: a prospective cohort study," (in eng)', 'volume': 'vol. 395', 'author': 'Cummings', 'year': '2020', 'journal-title': 'Lancet (London, England)'}, { 'key': '10.1016/j.jiph.2022.01.013_bib38', 'doi-asserted-by': 'crossref', 'first-page': 'm1996', 'DOI': '10.1136/bmj.m1996', 'article-title': 'Characterization and clinical course of 1000 patients with coronavirus ' 'disease 2019 in New York: retrospective case series," (in eng)', 'volume': 'vol. 369', 'author': 'Argenziano', 'year': '2020', 'journal-title': 'Bmj'}, { 'issue': '15', 'key': '10.1016/j.jiph.2022.01.013_bib39', 'doi-asserted-by': 'crossref', 'first-page': '896', 'DOI': '10.1093/cid/ciaa415', 'article-title': '"Obesity in Patients Younger Than 60 Years Is a Risk Factor for ' 'COVID-19 Hospital Admission," in', 'volume': 'vol. 71', 'author': 'Lighter', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'issue': '8', 'key': '10.1016/j.jiph.2022.01.013_bib40', 'doi-asserted-by': 'crossref', 'first-page': '649', 'DOI': '10.1159/000507940', 'article-title': '"Clinical Characteristics of Patients with Severe Pneumonia Caused by ' 'the SARS-CoV-2 in Wuhan, China," (in eng)', 'volume': 'vol. 99', 'author': 'Wang', 'year': '2020', 'journal-title': 'Respiration; international review of thoracic diseases'}, { 'issue': '1', 'key': '10.1016/j.jiph.2022.01.013_bib41', 'doi-asserted-by': 'crossref', 'DOI': '10.1186/s12879-020-05452-2', 'article-title': 'Clinical characteristics of 116 hospitalized patients with COVID-19 in ' 'Wuhan, China: a single-centered, retrospective, observational study," ' '(in eng)', 'volume': 'vol. 20', 'author': 'Xiong', 'year': '2020', 'journal-title': 'BMC infectious diseases'}, { 'issue': '5', 'key': '10.1016/j.jiph.2022.01.013_bib42', 'doi-asserted-by': 'crossref', 'first-page': '475', 'DOI': '10.1016/S2213-2600(20)30079-5', 'article-title': 'Clinical course and outcomes of critically ill patients with SARS-CoV-2 ' 'pneumonia in Wuhan, China: a single-centered, retrospective, ' 'observational study," (in eng)', 'volume': 'vol. 8', 'author': 'Yang', 'year': '2020', 'journal-title': 'Lancet Respir Med'}, { 'key': '10.1016/j.jiph.2022.01.013_bib43', 'first-page': '20037432', 'article-title': 'Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial', 'author': 'Chen', 'year': '2020', 'journal-title': 'medRxiv'}, { 'issue': '10229', 'key': '10.1016/j.jiph.2022.01.013_bib44', 'doi-asserted-by': 'crossref', 'first-page': '1054', 'DOI': '10.1016/S0140-6736(20)30566-3', 'article-title': 'Clinical course and risk factors for mortality of adult inpatients with ' 'COVID-19 in Wuhan, China: a retrospective cohort study," (in eng)', 'volume': 'vol. 395', 'author': 'Zhou', 'year': '2020', 'journal-title': 'Lancet'}, { 'issue': '16', 'key': '10.1016/j.jiph.2022.01.013_bib45', 'doi-asserted-by': 'crossref', 'first-page': '2089', 'DOI': '10.1093/cid/ciaa539', 'article-title': '"Risk Factors Associated With Clinical Outcomes in 323 Coronavirus ' 'Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, China," (in ' 'eng)', 'volume': 'vol. 71', 'author': 'Hu', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'issue': '15', 'key': '10.1016/j.jiph.2022.01.013_bib46', 'doi-asserted-by': 'crossref', 'first-page': '762', 'DOI': '10.1093/cid/ciaa248', 'article-title': '"Dysregulation of Immune Response in Patients With Coronavirus 2019 ' '(COVID-19) in Wuhan, China," (in eng)', 'volume': 'vol. 71', 'author': 'Qin', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'issue': '6', 'key': '10.1016/j.jiph.2022.01.013_bib47', 'doi-asserted-by': 'crossref', 'first-page': '607', 'DOI': '10.1016/j.jinf.2020.03.037', 'article-title': '"The pathogenesis and treatment of the `Cytokine Storm\' in COVID-19," ' '(in eng)', 'volume': 'vol. 80', 'author': 'Ye', 'year': '2020', 'journal-title': 'J Infect'}, { 'key': '10.1016/j.jiph.2022.01.013_bib48', 'doi-asserted-by': 'crossref', 'DOI': '10.1177/1753466620937175', 'article-title': '"C-reactive protein, procalcitonin, D-dimer, and ferritin in severe ' 'coronavirus disease-2019: a meta-analysis," (in eng)', 'volume': 'vol. 14', 'author': 'Huang', 'year': '2020', 'journal-title': 'Therapeutic advances in respiratory disease'}, { 'issue': '3', 'key': '10.1016/j.jiph.2022.01.013_bib49', 'doi-asserted-by': 'crossref', 'first-page': '548', 'DOI': '10.1007/s11239-020-02171-y', 'article-title': 'Evaluation of variation in D-dimer levels among COVID-19 and bacterial ' 'pneumonia: a retrospective analysis," (in eng)', 'volume': 'vol. 50', 'author': 'Yu', 'year': '2020', 'journal-title': 'J Thromb Thrombolysis'}, { 'issue': '2', 'key': '10.1016/j.jiph.2022.01.013_bib50', 'doi-asserted-by': 'crossref', 'DOI': '10.1183/23120541.00260-2020', 'article-title': '"D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a ' 'systematic review," (in eng)', 'volume': 'vol. 6', 'author': 'Vidali', 'year': '2020', 'journal-title': 'ERJ Open Res'}, { 'issue': '7', 'key': '10.1016/j.jiph.2022.01.013_bib51', 'doi-asserted-by': 'crossref', 'first-page': '934', 'DOI': '10.1001/jamainternmed.2020.0994', 'article-title': 'Risk Factors Associated With Acute Respiratory Distress Syndrome and ' 'Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, ' 'China," (in eng)', 'volume': 'vol. 180', 'author': 'Wu', 'year': '2020', 'journal-title': 'JAMA Intern Med'}, { 'issue': '7', 'key': '10.1016/j.jiph.2022.01.013_bib52', 'doi-asserted-by': 'crossref', 'first-page': '550', 'DOI': '10.1159/000502261', 'article-title': '"Immune-Modulation in Chronic Obstructive Pulmonary Disease: Current ' 'Concepts and Future Strategies," (in eng)', 'volume': 'vol. 99', 'author': 'van Eeden', 'year': '2020', 'journal-title': 'Respiration'}, { 'issue': '3', 'key': '10.1016/j.jiph.2022.01.013_bib53', 'doi-asserted-by': 'crossref', 'first-page': '364', 'DOI': '10.1007/s11427-020-1643-8', 'article-title': '"Clinical and biochemical indexes from 2019-nCoV infected patients ' 'linked to viral loads and lung injury," (in eng)', 'volume': 'vol. 63', 'author': 'Liu', 'year': '2020', 'journal-title': 'Sci China Life Sci'}, { 'key': '10.1016/j.jiph.2022.01.013_bib54', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.intimp.2021.107407', 'article-title': '"Serum cytokine levels of COVID-19 patients after 7 days of treatment ' 'with Favipiravir or Kaletra," (in eng)', 'volume': 'vol. 93', 'author': 'Mortaz', 'year': '2021', 'journal-title': 'International immunopharmacology'}, { 'issue': '6', 'key': '10.1016/j.jiph.2022.01.013_bib55', 'doi-asserted-by': 'crossref', 'first-page': '499', 'DOI': '10.7326/L20-0354', 'article-title': 'Cytokine Levels in the Body Fluids of a Patient With COVID-19 and Acute ' 'Respiratory Distress Syndrome: A Case Report," (in eng)', 'volume': 'vol. 173', 'author': 'Wang', 'year': '2020', 'journal-title': 'Annals of internal medicine'}, { 'issue': 'pp', 'key': '10.1016/j.jiph.2022.01.013_bib56', 'article-title': '"Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 ' 'pneumonia," (in eng)', 'volume': 'vol. 95', 'author': 'Solaymani-Dodaran', 'year': '2021', 'journal-title': 'International immunopharmacology'}, { 'issue': '2', 'key': '10.1016/j.jiph.2022.01.013_bib57', 'doi-asserted-by': 'crossref', 'first-page': '454', 'DOI': '10.1111/jcpt.13305', 'article-title': '"Observational study of the effects of Favipiravir vs ' 'Lopinavir/Ritonavir on clinical outcomes in critically Ill patients ' 'with COVID‐19,"', 'volume': 'vol. 46', 'author': 'Kocayiğit', 'year': '2021', 'journal-title': 'Journal of Clinical Pharmacy and Therapeutics'}, { 'key': '10.1016/j.jiph.2022.01.013_bib58', 'doi-asserted-by': 'crossref', 'first-page': '538', 'DOI': '10.1016/j.ijid.2020.11.008', 'article-title': 'Randomized controlled open label trial on the use of favipiravir ' 'combined with inhaled interferon beta-1b in hospitalized patients with ' 'moderate to severe COVID-19 pneumonia," (in eng)', 'volume': 'vol. 102', 'author': 'Khamis', 'year': '2021', 'journal-title': 'Int J Infect Dis'}, { 'issue': '5', 'key': '10.1016/j.jiph.2022.01.013_bib59', 'doi-asserted-by': 'crossref', 'first-page': '186', 'DOI': '10.1016/j.jinf.2020.12.005', 'article-title': '"Clinical efficacy and safety of favipiravir in the treatment of ' 'COVID-19 patients," (in eng)', 'volume': 'vol. 82', 'author': 'Chen', 'year': '2021', 'journal-title': 'The Journal of infection'}, { 'issue': '1', 'key': '10.1016/j.jiph.2022.01.013_bib60', 'doi-asserted-by': 'crossref', 'first-page': '141', 'DOI': '10.1186/s12985-020-01412-z', 'article-title': '"Favipiravir versus other antiviral or standard of care for COVID-19 ' 'treatment: a rapid systematic review and meta-analysis," (in eng)', 'volume': 'vol. 17', 'author': 'Shrestha', 'year': '2020', 'journal-title': 'Virol J'}], 'container-title': ['Journal of Infection and Public Health'], 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S1876034122000259?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S1876034122000259?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 2, 15]], 'date-time': '2022-02-15T18:29:10Z', 'timestamp': 1644949750000}, 'score': 1, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 2]]}, 'references-count': 60, 'alternative-id': ['S1876034122000259'], 'URL': 'http://dx.doi.org/10.1016/j.jiph.2022.01.013', 'relation': {}, 'ISSN': ['1876-0341'], 'issn-type': [{'value': '1876-0341', 'type': 'print'}], 'subject': [ 'Infectious Diseases', 'Public Health, Environmental and Occupational Health', 'General Medicine'], 'published': {'date-parts': [[2022, 2]]}}